Abstract:At present, there is no noninvasive prenatal testing (NIPT) method available for pregnant women that one partner of couples carry balanced chromosomal rearrangements (BCRs). Here we present a novel NIPT method for detecting foetal chromosomal rearrangements based on haplotype analysis of maternal cell-free foetal DNA (cffDNA) and demonstrate its effectiveness and potential for clinical application in a cohort of 46 patients. BCRs are estimated to occur in approximately 0.5% of newborn infants1 and the prevalence is even up to 4%–5% in individuals with fertility problems.2 BCRs can result in infertility, recurrent miscarriages, or offspring with congenital malformations.3, 4 In general, invasive prenatal diagnosis (IPD) such as amniocentesis is recommended after pregnancy for couples in which one partner carries BCRs. However, IPD poses a 0.5% risk of miscarriage, infection and preterm labour.5 Therefore, many couples decline IPD despite being BCR carriers. During pregnancy, maternal plasma contains a small percentage of cffDNA, which is an easily accessible source for the noninvasive determination of foetal chromosomal anomalies. The discovery has presented the possibility of noninvasive testing for genetic diseases; NIPT is now being increasingly used for detecting foetal chromosomal aneuploidies and monogenic disorders.6, 7 However, NIPT for structural chromosomal rearrangements (NIPT-SR) has not been available until now, despite its relatively high incidence. Core family-based haplotype linkage analysis has long been used to indirectly diagnose monogenic diseases, such as in preimplantation genetic testing (PGT) and NIPT.7, 8 In recent years, our team has illustrated haplotype analysis can also accurately detect balanced and unbalanced chromosome structural rearrangements in human embryos through PGT.9 The concept that foetal karyotypes can be predicted by inherited parental haplotypes was first introduced for NIPT in this study. The general workflow of our study was illustrated in Figure 1A. A total of 46 patients were recruited and participated in this research finally, peripheral blood of the couple and one patient's relative was collected, the karyotyping results of patients (Table 1) and their parents (Table S1) are shown. To achieve a highly accurate haplotype, we designed a capture-based single nucleotide polymorphism (SNP) panel that spanned 5.1 Mb regions and included 65 172 SNPs across the genome, with a median distance of 40 kb between each neighbouring SNP. Minor allele frequencies of these SNPs were more than 0.3 and the VIF threshold was set to 1.5, which could generate more informative markers and facilitate identification of the crossover more accurately. By library preparation and massively parallel sequencing, the average sequencing error rate was approximately 0.11%, indicating the high fidelity of data quality (Figure S1). To determine the parental allele inherited by the foetus, we first established the parental haplotypes through target-region sequencing genotyping data of the parents and one relative based on Mendel's law (Figure 1B). This strategy successfully helped construct the haplotypes on each chromosome carrying structural variants among the family members. After constructing the phased parental haplotypes, the foetal inheritance status could be inferred based on hidden Markov model (Figure 1B). All foetal haplotypes were successfully inferred in our cases, foetal karyotypes were then predicted according to the haplotypes transmitted around the rearrangement breakpoint regions. For example, in patient 6 (Figure 2), the pregnant woman was a balanced translation carrier and inherited the aberration from her mother (Figure 2B and C), targeted sequencing was conducted for the couple and grandmother and SNPs were then used to construct the parental haplotype (Figure 2D). For the inferred fatal haplotypes that covered the two suggested breakpoints, we found that the foetus inherited both the maternal haplotype M1, which was linked to the normal chromosome (Figure 2E and F). Thus, the foetus was predicted to have a normal karyotype, not be a BCR carrier (Figure S2). In addition, we identified one crossover in chromosome 1 and two crossovers in chromosome 20, the positions of the crossovers were accurately identified compared with the standard haplotype using the foetal genomic DNA. To further estimate the accuracy of the inferred foetal haplotype using this NIPT method, SNP genotypes those inferred from maternal plasma DNA sequencing were validated using direct sequencing results of foetal genomic DNA obtained from amniocentesis or blood. The average accuracy of inferred maternal and paternal alleles was 98.8% (Table S2), which was consistent with that reported in previous publications.10 Overall, an average of 1.63 informative SNPs were obtained in each Mb distance, and the positions of crossovers in the foetus could be accurately identified within one Mb. The distribution of total SNPs, average inferred SNPs and informative SNPs in each chromosome was shown (Figure S3), respectively. To validate the effectiveness of this proposed NIPT method, the results were confirmed by karyotyping analysis of foetal cells. Among all patients, 29 pregnant women underwent invasive prenatal amniocentesis in the second trimester and 7 pregnant women had their newborns' umbilical cord blood testing at birth, our results revealed that all foetal karyotypes were completely consistent with those detected using the NIPT method (Figure 3A). Further, in our study, 44 couples had conceived through PGT and their embryonic karyotypes were analysed at the blastocyst stage prior to transfer. Our study confirmed that all karyotype results diagnosed by PGT were consistent with those detected using the NIPT method after embryo transfer. The study strengths include its high accuracy and large sample size in the cohort, the rearranged chromosomes involve almost all 22 pairs of autosomes, proving that the noninvasive method is universal for different aspects of chromosomal rearrangements. To the best of our knowledge, this is the first report about a noninvasive approach to detect foetal balanced chromosomal rearrangements using maternal circulating cell-free foetal DNA. In conclusion, we develop a novel haplotype-based NIPT method for couples with BCRs and demonstrated this approach is applicable and universal for detecting a wide spectrum of chromosomal rearrangements in foetus. The proposed new NIPT-SR technology provides an option for these pregnant and will be an important supplement to the noninvasive prenatal diagnosis system for genetic diseases, reducing the possible miscarriage risk of IPD and facilitating the prevention of birth defects. We express deepest gratitude to all the families enrolled in our research. We would also like to thank the help of Mr. Hui Xu for sequencing experiment and data analysis (Chongqing Key Laboratory of Birth Defects and Reproductive Health, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University). We thank the staff of the Genetics Laboratory for their invaluable efforts and contribution in association with the experiment. The research was supported by Shanghai Science and Technology Innovation Action Plan Program (22Y11906600, 20Y11907200), National Natural Science Foundation of China (82201807) and Shanghai ‘Rising Stars of Medical Talents’ Youth Development Program. The authors declare that they do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Enrichment of circulating fetal nucleated red blood cell for non-invasive prenatal diagnosis with a new polyclonal antibody specific to fetal hemoglobin

Enrichment of Fetal Nucleated Red Blood Cell in Peripheral Blood of Pregnant Woman by Joint Use of Density Gradient Centrifugation and Keihuaer Acid-fast Staining

Aptamer-Mediated Enrichment of Rare Circulating Fetal Nucleated Red Blood Cells for Noninvasive Prenatal Diagnosis

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Frequency-enhanced transferrin receptor antibody-labelled microfluidic chip (FETAL-Chip) enables efficient enrichment of circulating nucleated red blood cells for non-invasive prenatal diagnosis.

Noninvasive detection of chromosomal CNV and single gene disease by massively parallel sequencing of cfDNA

Enrichment and Identification of Fetal Nucleated Red Blood Cells from Maternal Blood with Magnetic Nanoparticles and Quantum Dots

A Novel Noninvasive Prenatal Testing Method for Chromosomal Rearrangements Using Maternal Circulating Cell‐free Foetal DNA

Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders

Quantitative Analysis of Fetal RhD Genotyping with Fetal DNA from RhD-negative Maternal Plasma

Feasibility Study of Using Fetal DNA in Maternal Plasma for Non‐invasive Prenatal Diagnosis

Prenatal diagnosis of fetomaternal hemorrhage by a novel hydrogel fluoroimmunoassay that accurately quantifies fetal haemoglobin

Prenatal Determination of Fetal RhD Genotype by Real-Time PCR Examination of Fetal DNA in Maternal Plasma

Exploration of a Novel Noninvasive Prenatal Testing Approach for Monogenic Disorders Based on Fetal Nucleated Red Blood Cells

Examination of Fetal Sex in the Peripheral Blood of Pregnant Women before 9 Completed Weeks' Gestation

A novel method for noninvasive diagnosis of monogenic diseases from circulating fetal cells

Non-Invasive Prenatal Diagnosis of Chromosomal and Monogenic Disease by a Novel Bioinspired Micro–Nanochip for Isolating Fetal Nucleated Red Blood Cells

HUNTER-Chip: Bioinspired Hierarchically Aptamer Structure-Based Circulating Fetal Cell Isolation for Non-Invasive Prenatal Testing.

Detection of cell-free fetal DNA in maternal plasma using two types of compound markers.

Detection of Fetal Cells in Maternal Blood by Fluorescence in Situ Hybridization

Detection of Fetal Dna in Maternal Plasma by Microarray Coupled with Emulsions Pcr